Elanco Animal Health Incorporated Common Stock Earnings Dividend

Elanco Animal Health Incorporated Common Stock’s revenue jumped 10.23% since last year same period to $1368Mn in the Q2 2026. On a quarterly growth basis, Elanco Animal Health Incorporated Common Stock has generated -0.22% fall in its revenue since last 3-months.

Elanco Animal Health Incorporated Common Stock’s net profit jumped 390.91% since last year same period to $54Mn in the Q2 2026. On a quarterly growth basis, Elanco Animal Health Incorporated Common Stock has generated -5.26% fall in its net profits since last 3-months.

Elanco Animal Health Incorporated Common Stock’s net profit margin jumped 345.33% since last year same period to 3.95% in the Q2 2026. On a quarterly growth basis, Elanco Animal Health Incorporated Common Stock has generated -5.06% fall in its net profit margins since last 3-months.

Elanco Animal Health Incorporated Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.27 - a -20.59% fall from last quarter’s estimates.

Elanco Animal Health Incorporated Common Stock’s earning per share (EPS) estimates for the current year stand at 0.27.

Elanco Animal Health Incorporated Common Stock’s earning per share (EPS) jumped 30.77% since last year same period to 0.34 in the Q2 2026. This indicates that the Elanco Animal Health Incorporated Common Stock has generated 30.77% annual rate of jump in its earning per share (EPS) in the last 4 quarters.